NCT04610697

Brief Summary

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One empirically-validated method to train executive functions is cognitive remediation, which consists of cognitive exercises combined with coaching. This trial investigates whether cognitive remediation can improve cognitive, functional, and clinical outcomes in forensic inpatients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
Last Updated

December 12, 2025

Status Verified

April 1, 2025

Enrollment Period

6 years

First QC Date

October 26, 2020

Last Update Submit

December 4, 2025

Conditions

Keywords

Cognitive RemediationCognitive TrainingCognitive EnhancementCognitive RehabilitationNeuropsychological RehabilitationExecutive FunctionForensic Mental HealthForensic PsychologyForensic NeuropsychologyForensic NeuroscienceForensic RehabilitationCognitionExecutive Functioning

Outcome Measures

Primary Outcomes (1)

  • Executive Function

    We will measure executive functions using tests from the Cambridge Neuropsychological Test Automated Battery (CANTAB; Sandberg, 2011).

    within 1 week prior and 1 week after training, as well as at a 12-week follow-up.

Secondary Outcomes (3)

  • Oppositional Behavior

    within 12 weeks before and 12 weeks after training.

  • Functional Capacity

    within 1 week prior and 1 week after training, as well as at a 12-week follow-up.

  • Mental Health Symptoms

    within 1 week before and 1 week after training, as well as at a 12-week follow-up.

Study Arms (2)

Cognitive Remediation

EXPERIMENTAL

Participants in the cognitive remediation condition will complete computerised exercises followed by bridging discussions delivered using tele-heath. More details regarding treatment and control conditions will be provided following study completion to ensure participant blinding.

Behavioral: Cognitive Remediation

Active control

ACTIVE COMPARATOR

Participants in the active control condition will also complete computerised exercises followed by bridging discussions delivered using tele-heath. More details regarding treatment and control conditions will be provided following study completion to ensure participant blinding.

Behavioral: Active Control

Interventions

Cognitive Remediation consists of exercises, preferably supported by coaching, aimed at engaging cognitive skills and, as a result, at improving cognition as well as functional and clinical outcomes.

Also known as: Neuropsychological Rehabilitation, Cognitive Enhancement, Cognitive Rehabilitation
Cognitive Remediation
Active ControlBEHAVIORAL

Active control condition for cognitive remediation, matched in terms of session modality, number, duration, frequency, and format.

Active control

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • i1. Age 18 - 55; i2. Ability to read and speak in fluent English; i3. Current status as inpatient on the Forensic Treatment Unit.

You may not qualify if:

  • e1. Intellectual disability; e2. TBI with loss of consciousness followed by known severe neurological sequelae requiring hospitalisation and rehabilitation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Royal's Institute of Mental Health Research

Ottawa, Ontario, K1Z 7K4, Canada

RECRUITING

MeSH Terms

Conditions

Psychotic DisordersAttention Deficit Disorder with HyperactivityBrain Injuries, TraumaticAggressionSubstance-Related DisordersCognitive DysfunctionAnxiety DisordersDepressionSchizophreniaAntisocial Personality Disorder

Interventions

Cognitive RemediationCognitive Training

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersAttention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesAberrant Motor Behavior in DementiaBehavioral SymptomsBehaviorSocial BehaviorChemically-Induced DisordersCognition DisordersNeurocognitive DisordersPersonality Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesNeurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Patrizia Pezzoli, PhD

    UCL and The Royal's Institute of Mental Health Research

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Patrizia Pezzoli, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and personnel conducting the assessments will be unaware of group assignment. At the halfway mark of recruitment, we will perform preliminary analyses including intention-to-treat liner mixed models. Study staff performing the assessment visits and participants will remain blinded to the study conditions.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Double blind randomised controlled trial with active control condition. Given the clinically heterogeneous recruitment pool, pseudo-randomization will be employed to match groups on the main diagnosis.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2020

First Posted

October 30, 2020

Study Start

February 10, 2020

Primary Completion

February 10, 2026

Study Completion

February 10, 2026

Last Updated

December 12, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Anonymized datasets will be made available in appropriate online repositories to assist transparency and reproducibility.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
The data will be made available upon manuscript preparation (estimated fall 2021).
Access Criteria
Access information will be provided.
More information

Locations